Encorafenib and cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma: a multi-centric, multi-national, prospective, longitudinal, non-interventional study in Germany and Austria<br />

Bösartige Erkrankungen des unteren Verdauungstraktes (Darm, Leber/Gallenblase, Pankreas)

Karzinome des Dünn- und Dickdarms (Kolon, Rektum, Anus)

BRAF V600

BRAF

RAF (rapidly accelerated fibrosarcoma)

BRAF V600E

Anwendungsbeobachtung

BERING CRC

Efficacy Comparison of Dostarlimab Plus Chemotherapy vs Pembrolizumab plus Chemotherapy in Participants with metatstatic non-squamous non-small Cell Lung

Lungentumoren

Nicht-kleinzelliges Bronchialkarzinom (NSCLC)

EGFR

ROS-1 (c-ros oncogene 1, receptor tyrosine kinase)

Phase II

Perla

Metastatic

Comprehensive Cancer Center Mainfranken

Studien des CCC Mainfranken